Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2002
12/19/2002US20020192684 Arrays for detecting nucleic acids
12/19/2002US20020192682 Polynucleotides and polypeptides of the IFNalpha-2 gene
12/19/2002US20020192681 Detection of parasite in sample; obtain sample, isolate nucleotide sequences from dendritic cells, determine gene expression, presence of preferential gene indicates infections
12/19/2002US20020192680 Microcavity biosensor, methods of making, and uses thereof
12/19/2002US20020192679 Methods of using bone morphogenic proteins as biomarkers for determining cartilage degeneration and aging
12/19/2002US20020192678 Genes expressed in senescence
12/19/2002US20020192677 Amplification of preferential nucleotide sequences; obtain nucleic acid sample, incubate with primers and polymerase, amplify, recover nucleotide sequences
12/19/2002US20020192676 Classification of preferential bacteria; generate solid support, join antibodies to support that bind preferential bacteria, incubate with bacterial sample, recover bacteria, expose to spectrum analysis, classify bacteria
12/19/2002US20020192675 Detection of nucleotide sequences coding polypeptide associated with controlling gene expression; obtain cells, transform with nucleotide sequences coding regulatory polypeptides, monitor adjustment in preferential gene
12/19/2002US20020192672 Cell culture for use in the detection of ehrlichia infections
12/19/2002US20020192671 Evaluation of toxicity of compounds; obtain nucleotide sequences, expose to modulator, monitor response of gene to modulator
12/19/2002US20020192670 Novel fluorescent dye and method of measuring nucleic acid
12/19/2002US20020192669 Methods for preparation of nucleic acid for analysis
12/19/2002US20020192668 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002US20020192666 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cancer
12/19/2002US20020192665 Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
12/19/2002US20020192664 Devices and methods for optical detection of nucleic acid hybridization
12/19/2002US20020192663 Thermostable polymerases having altered fidelity and methods of identifying and using same
12/19/2002US20020192662 Method for determining the nucleotide sequence of a polynucleotide
12/19/2002US20020192661 Method for the direct, exponential amplification and sequencing of DNA molecules and its application
12/19/2002US20020192660 Reducing effect of regulatory sequences on transcription; obtain nucleotide sequences, detect regulatory sequences, mutate, transfect into cell, culture, monitor adjustment in transcription control
12/19/2002US20020192659 Secreted and transmembrane polypeptides and nucleic acids encoding the same
12/19/2002US20020192658 Biopolymer for use in the detection of preferential particle in sample
12/19/2002US20020192655 Determination of genotype associated with sensitivity to bipolar disorder; obtain nucleotide sequences from human, incubate with probe, recover nucleotide sequences, determine sequence, monitor for sensitivity to bipolar disorders
12/19/2002US20020192652 Obtaining a tissue sample of the tumor and non-malignant tissue; isolating mRNA; amplification using primers; determining the amount of HER2-neu mRNA; obtaining a differential HER2-neu epression level; determining
12/19/2002US20020192649 Unimolecular segment amplifiction and sequencing
12/19/2002US20020192648 Classification of microoganism; obtain nucleotide sequences from microorganism, incubate with primer, amplify, recover nucleotide sequences, electrophorese, evaluate pattern, compare to control, evaluate for similarities
12/19/2002US20020192647 Diagnostic method
12/19/2002US20020192646 Detecting malignant transformation of human cells, characterized in that overexpression of products of beta 3, beta 5, beta 8 and/or beta 9 genes, encoding hCG beta subunit, as compared with their expression in nonmalignant cells
12/19/2002US20020192645 BCR-ABL gene rearrangement assay method
12/19/2002US20020192644 Detection of natural killer receptor; obtain samples, incubate with oligonucleotides, detect bound complexes, presence of complexes indicates receptor
12/19/2002US20020192643 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
12/19/2002US20020192642 Diagnosing stomach cancer in humans; obtain fluid sample, detect Epstein Barr virus, the presence of the virus is an indication of stomach cancer
12/19/2002US20020192641 Measuring viral reverse transcriptase activity
12/19/2002US20020192640 Purified active HCV NS2/3 protease
12/19/2002US20020192637 Biological Sensor
12/19/2002US20020192636 Methods and apparatus for the discovery of growth promoting environments
12/19/2002US20020192635 Kits for use in monitoring and evaluating cell metabolism
12/19/2002US20020192634 EG-VEGF nucleic acids and polypeptides and methods of use
12/19/2002US20020192600 Probe carrier, probe fixing carrier and method of manufacturing the same
12/19/2002US20020192312 Pharmaceutical compositions
12/19/2002US20020192237 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis, and bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions
12/19/2002US20020192225 Methods of identifying bacterial genes that are incompatible with bacterial pathogenicity, and the use of such genes, such as cadA, to reduce pathogenicity in a bacteria or to combat pathogenic bacterial infections
12/19/2002US20020192220 Compositions and methods relating to colon specific genes and proteins
12/19/2002US20020192160 Novel human tumor suppressor gene
12/19/2002US20020192115 Biosensor
12/19/2002US20020191826 Polymerase chain reaction system
12/19/2002US20020189948 Electrophoresis separation media and methods
12/19/2002US20020189941 Biosensor
12/19/2002DE10131188A1 Screening method for identifying inhibitors of lipoprotein lipase, useful in pharmaceuticals and cosmetics, particularly for treatment of fatty deposits in the skin
12/19/2002DE10128400A1 New oligonucleotides are useful to detect filamentous bacteria in samples, particularly in activated sludge
12/19/2002DE10126798A1 Highly parallel determination of analytes, useful e.g. for diagnostic detection of proteins, by immobilization then contacting with surface carrying specific probes
12/19/2002DE10120798A1 Verfahren zur Bestimmung der Genexpression A method for determining the gene expression
12/19/2002CA2462173A1 Method for rapid amplification of dna
12/19/2002CA2455418A1 Systems and methods for the analysis of proteins
12/19/2002CA2454866A1 Methods of detecting, diagnosing and treating cancer and identifying neoplastic progression
12/19/2002CA2450752A1 Method for specific, fast detection of threadlike bacteria
12/19/2002CA2450671A1 Method for assessing the virulence of pathogens and uses thereof
12/19/2002CA2450403A1 Complete mitochondrial genome sequences as a diagnostic tool for the health sciences
12/19/2002CA2450397A1 Method of stabilizing reagent for amplifying or detecting nucleic acid and storage method
12/19/2002CA2450392A1 Culture medium for detecting and/or discriminating enterococcus and method therefor
12/19/2002CA2450389A1 Cyp450-specific dna probes and primers, and biological applications thereof
12/19/2002CA2450379A1 Molecular signatures of commonly fatal carcinomas
12/19/2002CA2450320A1 Dna sequencing method
12/19/2002CA2450139A1 Multiplexed detection methods
12/19/2002CA2450113A1 Vanilloid receptor-related nucleic acids and polypeptides
12/19/2002CA2450022A1 Method of testing drug for treating or preventing diseases such as hyperlipemia
12/19/2002CA2449654A1 Methods for treating disorders of the nervous and reproductive systems
12/19/2002CA2449649A1 A g-protein coupled receptor and uses therefor
12/19/2002CA2449602A1 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
12/19/2002CA2449560A1 Low-temperature cycle extension of dna with high priming specificity
12/19/2002CA2449440A1 Structural and cytoskeleton-associated proteins
12/19/2002CA2449279A1 A mouse unable to express functional alpha-4 integrin protein, and methods for assaying compounds or agents for alpha-4 integrin protein antagonist activity and a genetic marker for evaluating efficacy of modulators of signaling activity of a vla-4 receptor
12/19/2002CA2449272A1 Intracellular signaling molecules
12/19/2002CA2448719A1 Lipid structures and uses thereof
12/19/2002CA2447775A1 Process for evaluating phagocytotic function and use thereof
12/19/2002CA2445960A1 Method and apparatus for labeling and analyzing cellular components
12/19/2002CA2445509A1 Rapid methods for microbial typing and enumeration
12/18/2002EP1267295A1 A method and system for analyzing gene expression data using a smooth response surface algorithm
12/18/2002EP1267171A1 Cofactor-based screening method for nuclear receptor modulators
12/18/2002EP1267170A1 Method for characterising polypeptides
12/18/2002EP1267167A1 Method for identifying HCV entry factors
12/18/2002EP1267162A1 Simple method of biologically evaluating natural and artificial chemicals by using dna injury index and apparatus therefor
12/18/2002EP1266970A2 Detecting nucleic acid deletion sequences
12/18/2002EP1266969A1 Method for detecting dechlorination bacteria and method for treating earth or underground water polluted by chlorinated ethylene or chlorinated ethane, and nucleic acids used in the methods
12/18/2002EP1266958A1 Bio-chip substrate for the embedding of DNA or protein and its fabrication method
12/18/2002EP1266227A1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor
12/18/2002EP1266224A1 Modulation of histone deacetylase
12/18/2002EP1266202A2 Methods for detection of differences in nucleic acids
12/18/2002EP1266039A1 Method and kit for the screening, the detection and/or the quantification of transcriptional factors
12/18/2002EP1266038A2 Combined polynucleotide sequences as discrete assay endpoints
12/18/2002EP1266037A1 High throughput screening by measurement of intracellular calcium levels
12/18/2002EP1266035A1 Improved methods for generating catalytic proteins
12/18/2002EP1266034A2 Identification of biological (micro) organisms by detection of their homologous nucleotide sequences on arrays
12/18/2002EP1266033A1 Method of reverse transcription using bacillus steraothermophilus or thermoactinomyces vulgaris dna polymerase
12/18/2002EP1266032A1 Functionalized encapsulated fluorescent nanocrystals
12/18/2002EP1266031A1 Method for analysing the length of a nucleic acid molecule
12/18/2002EP1266030A2 Analysis of biological targets using a biochip comprising a fluorescent marker
12/18/2002EP1266029A1 Diagnosis of a person's risk of developing alcoholism
12/18/2002EP1266028A2 Method for quickly detecting microbial dna/rna, kit therefor and the use of said method